FundedIQ
Biotechnology

Alpheus Medical: Funding, Investors & Team (Sep 2026)

Alpheus Medical offers an innovative sonodynamic therapy platform for treating solid tumors and a non-invasive drug-device combination for outpatient treatment of recurrent glioblastoma multiforme (rGBM).

www.alpheusmedical.com LinkedIn Oakdale, United States 1-10 employees
Biotechnology Health Care Health Diagnostics Medical B2B
Total raised
$66.0M
Rounds
2
Latest
Series B
May 2025

Alpheus Medical has raised $66.0M across 2 funding rounds on record, the most recent a Series B of $52.0M announced in May 2025.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Alpheus Medical Company Profile and Key Stats

Total funding raised
$66.0M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Series B
$52.0M in May 2025
Employees
1-10
reported band
Headquarters
Oakdale, United States

Latest funding round on record: May 2025.

Alpheus Medical Funding Rounds

Date
Round
Amount
Series B
$52.0M
Series A
$14.0M

Alpheus Medical raised $14.0M in a Series A announced in Nov 2022.

2.5 years later, a Series B of $52.0M was announced in May 2025.

Alpheus Medical Founders and Leadership Team

Name
Role
Contact
Vijay Agarwal
Founder

No contact details are on record for this team yet.

Alpheus Medical Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M
4,307
$30M

Alpheus Medical's latest round of $52.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Alpheus Medical in Biotechnology and Oakdale

Companies Similar to Alpheus Medical

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Alpheus Medical Funding FAQs

What does Alpheus Medical do?

Alpheus Medical offers an innovative sonodynamic therapy platform for treating solid tumors and a non-invasive drug-device combination for outpatient treatment of recurrent glioblastoma multiforme (rGBM).

How much funding has Alpheus Medical raised?

Alpheus Medical has raised $66.0M across 2 rounds on record. The most recent is a Series B of $52.0M announced in May 2025.

When did Alpheus Medical last raise funding?

Alpheus Medical's most recent funding round on record is a Series B of $52.0M, announced in May 2025.

Who founded Alpheus Medical?

FundedIQ lists Vijay Agarwal (Founder) at Alpheus Medical.

Where is Alpheus Medical headquartered?

Alpheus Medical is based in Oakdale, Pennsylvania, United States.

How many employees does Alpheus Medical have?

Alpheus Medical is in the 1-10 employee band.

How does Alpheus Medical's funding compare to other Biotechnology startups?

Alpheus Medical's latest round of $52.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Alpheus Medical Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Alpheus Medical is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.